Thanks, Mozz, your "technical"posts are always especially informative. Two little queries however. You have "always" assumed that the p-values from the 008 study will improve dramatically in any subsequent study involving a larger number of participants. Probably, hopefully, this will turn out to be the case but you seem to assume that this is nearly axiomatic. Presumably a larger study is more reliable, but this implies that the initial smaller study is less reliable, which suggests we should be careful not to put so much weight on such a study. Also, is it wise to jump from an effect on canines after 26 weeks to so confidently assume a similar effect on humans after 3 years. That seems to be a stretch for me. Again, thanks for your research which I am sure is invaluable for most of us.
- Forums
- ASX - By Stock
- PAR
- The Phase III Primer!
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
3.03%
!
32.0¢

The Phase III Primer!, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
32.0¢ |
Change
-0.010(3.03%) |
Mkt cap ! $128.1M |
Open | High | Low | Value | Volume |
33.5¢ | 33.5¢ | 31.8¢ | $203.1K | 627.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 56119 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 21328 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 53945 | 0.320 |
9 | 66711 | 0.315 |
10 | 78768 | 0.310 |
9 | 148549 | 0.305 |
18 | 188088 | 0.300 |
Price($) | Vol. | No. |
---|---|---|
0.325 | 65701 | 7 |
0.330 | 53726 | 7 |
0.335 | 12734 | 5 |
0.340 | 66200 | 5 |
0.350 | 13889 | 5 |
Last trade - 10.58am 08/08/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |